These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4797171)

  • 1. L-prolyl-L-leucyl-glycinamide (PLG): influences on locomotor and stereotyped behavior of cats.
    North RB; Harik SI; Snyder SH
    Brain Res; 1973 Dec; 63():435-9. PubMed ID: 4797171
    [No Abstract]   [Full Text] [Related]  

  • 2. General activity in intact and hypophysectomized rats after administration of melanocyte-stimulating hormone (MSH), melatonin, and PRO-LEU-GLY-NH 2 .
    Kastin AJ; Miller MC; Ferrell L; Schally AV
    Physiol Behav; 1973 Feb; 10(2):399-401. PubMed ID: 4575310
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopamine synthesis: stimulation by a hypothalamic factor.
    Friedman E; Friedman J; Gershon S
    Science; 1973 Nov; 182(4114):831-2. PubMed ID: 4746492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution, half-life, and excretion of 14 C- and 3 H-labeled L-prolyl-L-leucyl-glycinamide in the rat.
    Redding TW; Kastin AJ; Nair RM; Schally AV
    Neuroendocrinology; 1973; 11(2):92-100. PubMed ID: 4697489
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and allosteric modulation of the dopamine receptor by peptide analogs of L-prolyl-L-leucyl-glycinamide (PLG) modified in the L-proline or L-proline and L-leucine scaffolds.
    Ferreira da Costa J; Caamaño O; Fernández F; García-Mera X; Sampaio-Dias IE; Brea JM; Cadavid MI
    Eur J Med Chem; 2013 Nov; 69():146-58. PubMed ID: 24013414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxotremorine antagonism by prolyl-leucyl-glycine-amide administered by different routes and with several anticholinergics.
    Plotnikoff NP; Kastin AJ
    Pharmacol Biochem Behav; 1974 May; 2(3):417-9. PubMed ID: 4837910
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypothalamic releasing factors and Parkinson disease.
    Chase TN; Woods AC; Lipton MA; Morris CE
    Arch Neurol; 1974 Jul; 31(1):55-6. PubMed ID: 4209275
    [No Abstract]   [Full Text] [Related]  

  • 8. Action of two hypothalamic factors (TRH, MIF) and of angiotensin II on the behavioral effects of L-DOPA and 5-hydroxytryptophan in mice.
    Huidobro-Toro JP; De Carolis AS; Longo VG
    Pharmacol Biochem Behav; 1974; 2(1):105-9. PubMed ID: 4364044
    [No Abstract]   [Full Text] [Related]  

  • 9. Deserpidine antagonism by a tripeptide, L-prolyl-L-leucyglycinamide.
    Plotnikoff NP; Kastin AJ; Anderson MS; Schally AV
    Neuroendocrinology; 1973; 11(1):67-71. PubMed ID: 4633626
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of MSH release in frogs by direct application of L-proplyl-L-leucylglycinamide to the pituitary.
    Kastin AJ; Schally AV; Viosca S
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1437-9. PubMed ID: 5316453
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of L-prolyl-L-leucyl-glycinamide.
    Ott MC; Mishra RK; Johnson RL
    Brain Res; 1996 Oct; 737(1-2):287-91. PubMed ID: 8930377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that Pro-Leu-Gly-NH 2 , tocinoic acid, and des-Cys-tocinoic acid do not affect secretion of melanocyte stimulating hormone.
    Grant NH; Clark DE; Rosanoff EI
    Biochem Biophys Res Commun; 1973 Mar; 51(1):100-6. PubMed ID: 4540644
    [No Abstract]   [Full Text] [Related]  

  • 13. The Yawning elicited by alpha-melanocyte-stimulating hormone involves serotonergic-dopaminergic-cholinergic neuron link in rats.
    Yamada K; Furukawa T
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Apr; 316(2):155-60. PubMed ID: 6972489
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of amino acid derivatives of beta-carboline-3-carboxylate on rat behavior].
    Pliashkevich IuG; Barsegian GG; Ponomarev SIu; Demushkin VP
    Biull Eksp Biol Med; 1989 May; 107(5):586-7. PubMed ID: 2736294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differential role of the caudate nucleus and the linear raphe nucleus in the initiation and the maintenance of morphine-induced behaviour in cats.
    Cools AR; Janssen HJ; Broekkamp CL
    Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):163-74. PubMed ID: 4474848
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacology of L-prolyl-L-leucyl-glycinamide (PLG): a review.
    Mishra RK; Chiu S; Chiu P; Mishra CP
    Methods Find Exp Clin Pharmacol; 1983; 5(4):203-33. PubMed ID: 6136640
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of the neuropeptide PLG (L-prolyl-leucyl-glycinamide) on writing pressure and speed in healthy subjects.
    Steinwachs KC; Fehm HL
    Pharmacopsychiatry; 1988 Nov; 21(6):459-60. PubMed ID: 3244794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolyl-leucyl-glycinamide shares some effects with oxytocin but decreases oxytocin levels.
    Petersson M; Uvnäs-Moberg K
    Physiol Behav; 2004 Dec; 83(3):475-81. PubMed ID: 15581670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate: diurnal effects on locomotor and stereotypic behavior in the rat.
    Gaytan O; Ghelani D; Martin S; Swann A; Dafny N
    Brain Res; 1997 Nov; 777(1-2):1-12. PubMed ID: 9449407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual and chemical release of feeding behavior in adult rainbow trout.
    Valentincic T; Caprio J
    Chem Senses; 1997 Aug; 22(4):375-82. PubMed ID: 9279460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.